Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. 1983

A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar

Transplacental transmission of hepatitis B virus infection was studied in 51 Senegalese neonates born to mothers who were chronic carriers of HBsAg. 13 mothers were positive for both HBsAg and HBeAg. Mother-to-infant transmission of these two markers was different with 3 children being HBsAg positive and HBeAg negative at birth and 6 being HBsAg negative but HBeAg positive. At birth none of the 51 children had anti-HBc IgM detected by a highly specific enzyme immunoassay, indicating that none had had a primary immune response in utero to HBV infection. These HBV serum markers in newborn infants indicate contamination by maternal blood at delivery rather than active infection in utero. Prophylaxis at birth is advisable in children of mothers who are chronic carriers.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti

Related Publications

A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
September 1988, Annals of tropical paediatrics,
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
April 1979, Pediatrics,
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
September 1984, Klinische Wochenschrift,
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
September 1974, Lancet (London, England),
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
June 1985, Medicina clinica,
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
October 1983, British medical journal (Clinical research ed.),
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
January 1981, Journal of medical virology,
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
January 1992, Journal of medical virology,
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
November 2012, Histopathology,
A Goudeau, and B Yvonnet, and G Lesage, and F Barin, and F Denis, and P Coursaget, and J P Chiron, and I Diop Mar
November 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Copied contents to your clipboard!